These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12519872)

  • 1. Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity.
    Heikinheimo O; Raivio T; Honkanen H; Ranta S; Jänne OA
    J Clin Endocrinol Metab; 2003 Jan; 88(1):323-6. PubMed ID: 12519872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy.
    Heikinheimo O; Suhonen S; Haukkamaa M
    Reprod Biomed Online; 2004 Feb; 8(2):236-9. PubMed ID: 14989807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical abortion.
    Bardin CW; Robbins A; O'Connor BM; Spitz I
    Curr Ther Endocrinol Metab; 1997; 6():305-11. PubMed ID: 9174759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancy.
    Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):134-9. PubMed ID: 15683372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound evaluation of the endometrium after medical termination of pregnancy.
    Cowett AA; Cohen LS; Lichtenberg ES; Stika CS
    Obstet Gynecol; 2004 May; 103(5 Pt 1):871-5. PubMed ID: 15121559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment.
    Kajantie E; Raivio T; Jänne OA; Hovi P; Dunkel L; Andersson S
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3999-4003. PubMed ID: 15292340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation assay for determination of glucocorticoid bioactivity in human serum.
    Raivio T; Palvimo JJ; Kannisto S; Voutilainen R; Jänne OA
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3740-4. PubMed ID: 12161504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early pregnancy termination with mifepristone and misoprostol in the United States.
    Spitz IM; Bardin CW; Benton L; Robbins A
    N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA and their protein expression levels in human decidua after early pregnancy termination by mifepristone plus misoprostol.
    Huang L; Shi Y
    Chin Med J (Engl); 2001 Jun; 114(6):628-31. PubMed ID: 11780441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
    Chai J; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
    Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL
    J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulation resumption after medical abortion with mifepristone and misoprostol.
    Schreiber CA; Sober S; Ratcliffe S; Creinin MD
    Contraception; 2011 Sep; 84(3):230-3. PubMed ID: 21843685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone dose in the regimen with misoprostol for medical abortion.
    Marions L
    Contraception; 2006 Jul; 74(1):21-5. PubMed ID: 16781255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.